-
Product Name
LDB3 antibody
- Documents
-
Description
LDB3 Rabbit Polyclonal antibody. Positive IHC detected in human prostate cancer. Positive WB detected in human skeletal muscle tissue. Observed molecular weight by Western-blot: 32kd, 78-80kd
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
human, mouse, rat; other species not tested.
-
Alternative names
LDB3 antibody; FLJ35865 antibody; KIAA01613 antibody; LIM domain binding 3 antibody; ldb3z1 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of LDB3 recombinant protein (Accession Number: XM_017015609). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IHC: 1:20-1:200
-
Validations
human skeletal muscle tissue were subjected to SDS PAGE followed by western blot with Catalog No:112180(LDB3 antibody) at dilution of 1:1000
Immunohistochemical of paraffin-embedded human prostate cancer using Catalog No:112180(LDB3 antibody) at dilution of 1:50 (under 10x lens)
-
Background
LDB3 represents LIM domain binding 3
-
References
- Garton FC, Seto JT, Quinlan KG, Yang N, Houweling PJ, North KN. α-Actinin-3 deficiency alters muscle adaptation in response to denervation and immobilization. Human molecular genetics. 23(7):1879-93. 2014.
- Hogarth MW, Garton FC, Houweling PJ. Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion. Human molecular genetics. 25(5):866-77. 2016.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"